JP2013527164A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013527164A5 JP2013527164A5 JP2013506767A JP2013506767A JP2013527164A5 JP 2013527164 A5 JP2013527164 A5 JP 2013527164A5 JP 2013506767 A JP2013506767 A JP 2013506767A JP 2013506767 A JP2013506767 A JP 2013506767A JP 2013527164 A5 JP2013527164 A5 JP 2013527164A5
- Authority
- JP
- Japan
- Prior art keywords
- dosage form
- polyoxyethylene
- tadalafil
- citrate
- ester
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32796910P | 2010-04-26 | 2010-04-26 | |
| US61/327,969 | 2010-04-26 | ||
| US13/079,348 US20110263606A1 (en) | 2010-04-26 | 2011-04-04 | Solid oral dosage forms comprising tadalafil |
| US13/079,348 | 2011-04-04 | ||
| PCT/IB2011/000882 WO2011135426A1 (en) | 2010-04-26 | 2011-04-22 | Solid oral dosage forms comprising tadalafil |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013527164A JP2013527164A (ja) | 2013-06-27 |
| JP2013527164A5 true JP2013527164A5 (https=) | 2014-04-10 |
Family
ID=44816306
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013506767A Pending JP2013527164A (ja) | 2010-04-26 | 2011-04-22 | タダラフィルを含む固体経口剤形 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US20110263606A1 (https=) |
| EP (1) | EP2563346A4 (https=) |
| JP (1) | JP2013527164A (https=) |
| CA (1) | CA2797444A1 (https=) |
| WO (1) | WO2011135426A1 (https=) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10610528B2 (en) | 2009-12-08 | 2020-04-07 | Intelgenx Corp. | Solid oral film dosage forms and methods for making same |
| US20110136815A1 (en) | 2009-12-08 | 2011-06-09 | Horst Zerbe | Solid oral film dosage forms and methods for making same |
| GB2497728A (en) | 2011-12-14 | 2013-06-26 | Londonpharma Ltd | Statin formulations for transmucosal delivery |
| GB2497933B (en) * | 2011-12-21 | 2014-12-24 | Londonpharma Ltd | Drug delivery technology |
| WO2013109230A1 (en) * | 2012-01-18 | 2013-07-25 | Mahmut Bilgic | Pharmaceutical compositions comprising tadalafil |
| WO2013109221A1 (en) * | 2012-01-18 | 2013-07-25 | Mahmut Bilgic | New effervescent formulations comprising sweetener composition |
| WO2014027981A2 (en) * | 2012-08-17 | 2014-02-20 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Effervescent tablet formulations of dapoxetine and a pde5 inhibitor |
| WO2014027975A2 (en) * | 2012-08-17 | 2014-02-20 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Novel orally administered pharmaceutical formulations |
| WO2014027982A2 (en) * | 2012-08-17 | 2014-02-20 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Novel effervescent sachet formulations of dapoxetine and a pde5 inhibitor |
| US20150202168A1 (en) * | 2012-08-17 | 2015-07-23 | Sanovel llac Sanayi Ve Ticaret Anonim Sirketi | Oral film formulations comprising dapoxetine and tadalafil |
| MY173159A (en) * | 2013-04-11 | 2019-12-31 | Ctc Bio Inc | Tadalafil free base-containing film dosage form containing polyethylene glycol-based polymer and/or vinyl pyrrolidone-based polymer as dispersion stabilizer |
| US11116769B2 (en) | 2013-04-11 | 2021-09-14 | Ctc Bio, Inc. | Tadalafil free base-containing film dosage form containing polyethylene glycol-based polymer and/or vinyl pyrrolidone-based polymer as dispersion stabilizer |
| KR102239291B1 (ko) * | 2013-06-28 | 2021-04-14 | 한미약품 주식회사 | 타다라필 또는 이의 약학적으로 허용가능한 염을 포함하는 저작정 제제 |
| EP3427732A1 (en) * | 2013-07-31 | 2019-01-16 | Intelgenx Corporation | Instantly wettable oral film dosage form without surfactant or polyalcohol |
| KR20150138671A (ko) * | 2014-06-02 | 2015-12-10 | 에스케이케미칼주식회사 | 타달라필을 함유하는 구강 붕해 필름 및 이의 제조방법 |
| KR101562197B1 (ko) * | 2014-06-24 | 2015-10-23 | (주)우신메딕스 | 타다라필을 함유하는 구강 붕해형 필름 제제 및 이의 제조방법 |
| KR101538985B1 (ko) * | 2014-09-02 | 2015-07-24 | 주식회사 서울제약 | 타다라필 구강붕해필름 및 이의 제조방법 |
| CZ2016570A3 (cs) * | 2016-09-15 | 2018-03-28 | Zentiva, K.S. | Stabilní kompozice ODF obsahující těžce rozpustné terapeutické činidlo |
| CZ2017781A3 (cs) * | 2017-12-05 | 2019-06-12 | Zentiva, K.S. | Těžko rozpustné terapeutická činidla,která patřící do BCS skupiny II nebo IV, suspendovaná v kapalné formulaci a/nebo v konečné nanovláknité struktuře |
| EP3749370B1 (de) * | 2018-02-07 | 2025-05-07 | Smawa GmbH | Pharmazeutische formulierungen, verfahren zum herstellen einer pharmazeutischen formulierung sowie ein arzneimittel umfassend eine solche |
| CN109157520B (zh) * | 2018-09-07 | 2021-04-02 | 苏州科技城医院 | 他达拉非片剂及其制备方法 |
| US10828254B2 (en) | 2018-09-28 | 2020-11-10 | Intelgenx Corp. | Oral film formulation for modulating absorption profile |
| US12303501B2 (en) | 2018-11-05 | 2025-05-20 | Intelgenx Corp. | Lipophilic active oral film formulation and method of making the same |
| US12440472B2 (en) | 2021-06-16 | 2025-10-14 | Intelgenx Corp. | Stable tryptamine oral films |
| WO2023232215A1 (en) * | 2022-06-02 | 2023-12-07 | Rontis Hellas S.A. | Improved pharmaceutical composition containing tadalafil and process for the preparation thereof |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19646392A1 (de) * | 1996-11-11 | 1998-05-14 | Lohmann Therapie Syst Lts | Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht |
| ES2187234A1 (es) * | 1999-04-30 | 2003-05-16 | Lilly Icos Llc | Forma de dosificacion oral para tratar la disfuncion sexual. |
| JP2008546786A (ja) * | 2005-06-23 | 2008-12-25 | シェーリング コーポレイション | Ｐｄｅ５インヒビターの迅速吸収性経口処方物 |
| JP4234786B1 (ja) * | 2005-11-08 | 2009-03-04 | ファイザー・リミテッド | ピラゾール誘導体およびその医学的使用 |
| US9532945B2 (en) * | 2006-04-04 | 2017-01-03 | Kg Acquisition Llc | Oral dosage forms including an antiplatelet agent and an enterically coated acid inhibitor |
| KR101140110B1 (ko) * | 2006-07-07 | 2012-06-04 | 테바 파마슈티컬 인더스트리즈 리미티드 | 타달라필 및 하나 이상의 담체를 포함하는 고체 조성물 |
| KR20100012867A (ko) * | 2007-04-25 | 2010-02-08 | 테바 파마슈티컬 인더스트리즈 리미티드 | 타다라필을 포함하는 고체 제형 |
| US20080292683A1 (en) * | 2007-05-24 | 2008-11-27 | Monosolrx, Llc. | Film shreds and delivery system incorporating same |
| DE102007028869A1 (de) * | 2007-06-22 | 2008-12-24 | Ratiopharm Gmbh | Verfahren zur Herstellung eines Arzneimittels enthaltend Tadalafil |
| US20090047330A1 (en) * | 2007-08-17 | 2009-02-19 | Ramesh Bangalore | Oral fast dissolving films for erectile dysfunction bioactive agents |
| MX2010004265A (es) * | 2007-10-19 | 2010-07-28 | Innozen Inc | Composicion para administrar un ingrediente activo y metodo para hacer y usar el mismo. |
| KR101074271B1 (ko) * | 2009-06-25 | 2011-10-17 | (주)차바이오앤디오스텍 | 불쾌한 맛을 효과적으로 은폐한 경구용 속용 필름 |
-
2011
- 2011-04-04 US US13/079,348 patent/US20110263606A1/en not_active Abandoned
- 2011-04-22 WO PCT/IB2011/000882 patent/WO2011135426A1/en not_active Ceased
- 2011-04-22 CA CA2797444A patent/CA2797444A1/en not_active Abandoned
- 2011-04-22 JP JP2013506767A patent/JP2013527164A/ja active Pending
- 2011-04-22 EP EP11774495.3A patent/EP2563346A4/en not_active Withdrawn
-
2017
- 2017-11-27 US US15/822,734 patent/US20180078549A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013527164A5 (https=) | ||
| US20110263606A1 (en) | Solid oral dosage forms comprising tadalafil | |
| JP2015531377A5 (https=) | ||
| EP3431075A1 (en) | Edaravone dosage form | |
| JP2012025755A5 (https=) | ||
| JP2017536398A5 (https=) | ||
| JP2018504443A5 (https=) | ||
| JP2007528388A5 (https=) | ||
| JP2015527395A5 (https=) | ||
| JP2012530719A5 (https=) | ||
| RU2015154403A (ru) | Офтальмическая наноэмульсионная композиция, содержащая циклоспорин и способ ее получения | |
| JP2015504924A5 (https=) | ||
| RU2013126259A (ru) | Фармацевтическая композиция таксоидов | |
| JP2015516418A5 (https=) | ||
| US20100021538A1 (en) | Pharmaceutical compositions containing heparin derivatives | |
| JP2017508802A5 (https=) | ||
| JP2014503479A (ja) | アリピプラゾール組成物及びその経皮送達のための方法 | |
| RU2017142563A (ru) | Твердые дисперсии q10 | |
| WO2017037647A1 (en) | Stable pharmaceutical compositions of abiraterone | |
| CA2617140A1 (en) | Pharmaceutical formulation with high stability and dissolution and manufacturing process | |
| WO2016163403A1 (ja) | 経口フィルム製剤 | |
| RU2014101990A (ru) | Жидкая фармацевтическая композиция, включающая нитизинон | |
| HRP20151051T1 (hr) | Formulacije src/abl inhibitora | |
| AR078785A1 (es) | Formulaciones de bazedoxifeno con antioxidantes | |
| JP5734331B2 (ja) | 二環式化合物を含む医薬組成物およびその二環式化合物の安定化方法 |